Hypofractionated Stereotactic Radiotherapy

RADIATION7 trials

Conditions

Brain MetastasesBrain Metastases, AdultCancerCancer BrainGlioblastomaGlioblastoma MultiformeGlioblastoma, IDH-wildtypeGlioma

Phase 1

Perfexion Brain Metastasis

TerminatedNCT00805103

University Health Network, TorontoBrain Metastases

Start: 2008-12-31End: 2016-03-31Updated: 2016-12-29

Bevacizumab and ICIs + hSRT in Symptomatic Melanoma Brain Metastases

RecruitingNCT06163820

Melanoma and Skin Cancer Trials LimitedMelanoma Brain Metastases

Start: 2025-05-31End: 2026-01-30Target: 46Updated: 2025-05-13

Neoadjuvant Radio-chemotherapy Safety Pilot Study in Patients With Glioblastoma

RecruitingNCT06418113

Hospital San Carlos, MadridCancer Brain, Glioblastoma, Glioblastoma, IDH-wildtype +2

Start: 2024-03-21End: 2027-03-21Target: 12Updated: 2024-05-16

Phase 2

Exclusive Hypofractionated Stereotactic Radiotherapy in Non-resectable Single Brain Metastasis

WithdrawnNCT01169116

Barretos Cancer HospitalCancer, Metastasis

Start: 2010-07-31Updated: 2014-02-04

Hypofractionated Stereotactic Radiotherapy With Anlotinib in Patients With Recurrent High-Grade Gliomas

Active, not recruitingNCT04197492

Huashan HospitalMalignant Glioma

Start: 2019-12-16End: 2024-12-31Target: 22Updated: 2024-01-05

Low-dose Bevacizumab With HSRT vs BVZ Alone for GBM at First Recurrence

NCT05611645

Huashan HospitalGlioma, Recurrent Glioma

Start: 2022-10-01End: 2025-12-31Target: 42Updated: 2022-11-10

Unknown Phase

A Neurocognitive Study in Patients With Brain Oligometastases Receiving Hypofractionated SRT

RecruitingNCT04805255

Chang Gung Memorial HospitalBrain Metastases, Adult

Start: 2021-02-25End: 2027-03-10Target: 135Updated: 2023-05-01

Related Papers

Safety and efficacy of CyberKnife radiosurgery plus anlotinib hydrochloride in patients with recurrent glioblastoma: A prospective phase II single-arm study.

Journal of Clinical Oncology2024-06-011 citations

Safety and Efficacy of Hypofractionated Stereotactic Radiotherapy with Anlotinib Targeted Therapy for Glioblastoma at the First Recurrence: A Preliminary Report

Brain Sciences2022-04-0210 citations

Safety and efficacy of hypofractionated stereotactic radiosurgery with anlotinib targeted therapy for glioblastoma at first recurrence: A preliminary report.

Journal of Clinical Oncology2021-05-20

Safety and efficacy of Hypofractionated stereotactic radiosurgery for high-grade Gliomas at first recurrence: a single-center experience.

2021-02-0517 citations